Skip to Content

Clinical Trials
Patient Portal

Loading component...

Loading component...

Ph1a/b LOXO-435 in Solids with FGFR3 Alterations

Phase I Clinical Trial

AN OPEN-LABEL MULTICENTER STUDY OF LOXO-435 (LY3866288) IN ADVANCED SOLID TUMOR MALIGNANCIES WITH FGFR3 ALTERATIONS (LOXO-FG3-22001)

Indication: Urothelial Cancer

Trial Number: 05614739

Trial Status: OPEN

Learn more about this clinical trial.

About Us
Specialities & Services
Request Appointment
Careers
Contact Us
Media Center
Cancer Support Services
Careopolis

Find a Provider
Find a Location
Clinical Trials
Patient Portal
Patient Forms
Patient Resources
Patient Rights & Privacy
Insurance Information

© 2026 Texas Oncology. All rights reserved.|Privacy Notice|Terms of Use